CD44 and posterior cortical atrophy: Knocking down either CD44 or CD147 along with multi-drug resistance protein-2 (MRP2) and transporter protein (MCT4) reduces both p-Akt and p-Erk in PCa cells, while docetaxel sensitivity is increased, which affects PCa metastasis and chemoresistance [115].